摘要
目的:探讨G-CSF基因治疗配合大剂量化疗后的体内抗结肠癌肝转移的效果及其可能的机制。方法:制备C-26结肠癌肝转移小鼠模型,观察成纤维细胞介导的腹腔途径G-CSF基因治疗及其配合大剂量5-Fu后抗结肠癌肝转移的效果。结果:腹腔单独注射大剂量5-Fu或rhG-CSF后可明显地抑制C-26肝转移结节形成(P<0.05),而腹腔内成纤维细胞介导的G-CSF基因疗法的抗C-26肝转移的作用更明显(P<0.01);配合大剂量5-Fu后,G-CSF基因疗法抗C-26肝转移的效果比单独应用rhG-CSF或G-CSF基因治疗更明显,且优于rhG-CSF注射疗法与大剂量5-Fu联合的治疗效果。经G-CSF基因治疗后小鼠腹腔巨噬细胞吞噬功能、抗原提呈能力、杀伤活性,以及分泌TNF、NO、IL-1的能力均有明显提高。结论:G-CSF基因治疗配合大剂量化疗可有效地抗结肠癌肝转移,腹腔巨噬细胞功能的增强可能是其机制之一。
Objective: To examine the antimetastatic effect of fibroblastsmediated GCSF gene therapy and highdose chemotherapy on C26 colon adenocarcinomabearing mice and its mechanism. Methods: Experimental liver metastasis model in C26 colon adenocarcinoma mice was prepared by splenic injection of 1×105 C26 cells into BALB/c mouse. Then the tumorbearing mice were injected i.p. with rhGCSF (2 μg/d×14 d) or implanted with 1×107 collagen encapsulated NIH3T3GCSF cells secreting GCSF after gene transfection. Results: The number of liver metastasis was reduced by 5Fu,rhGCSF or GCSF gene therapy, respectively, showing that both rhGCSF and GCSF gene therapy has exact antimetastatic effect and GCSF gene therapy was more effective than rhGCSF injection in vivo. Better results could be observed in C26bearing mice receiving highdose 5Fu after GCSF gene therapy, suggesting that GCSF gene therapy could inhibit the liver metastasis more effectively in C26bearing mice receiving highdose chemotherapy than rCSF injection plus 5Fu and augment the cytotoxicity and the antigenpresenting activity of the peritoneal macrophages significantly. The secretions of IL1,TNF,NO by macrophages were also significantly enhanced. Conclusion: GCSF gene therapy in combination with highdose chemotherapy could inhibit metastasis of colon carcinoma to liver effectively and one of its mechanisms may be the activation of peritoneal macrophages .
出处
《第二军医大学学报》
CAS
CSCD
北大核心
1998年第1期13-16,共4页
Academic Journal of Second Military Medical University
基金
军队"九五"医药科研规划重点课题
关键词
基因治疗
巨噬细胞
结肠肿瘤
肝转移
G-CSF
granulocyte colonystimulating factor
gene therapy
macrophage
colon neoplasms
liver metastasis